Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2013


3rd Serialization and Traceability for Brand Protection

09 May 2013 - 10 May 2013 - Philadelphia, PA, USA



Bookmark and Share


ExL Pharma’s 3rd Life Science Serialization and Traceability For Brand Protection is the premier event providing pharmaceutical & life science companies with comprehensive take-back-to-the-office serialization, traceability and e-pedigree strategies.

While there is a continued lack of federal guidance, it is still imperative to make the business case for your organization for brand protection purposes. If the supply chain partners are buttoned up throughout your drug’s journey to the customer, you are adding significant value to your brand by not allowing counterfeit or rogue drugs to damage your reputation.

The 2013 event will challenge the audience with new perspectives, speakers, formats and topics not often seen on the conference circuit, including:

Preparing pharma for California’s 2014/15 serialization mandate.

Learning from other industries:  How The Auto Industry Embraced and Integrated Serialization & Track & Trace

End to End Traceability doesn’t end with the wholesaler: Perspectives from pharmacies, hospitals and consumers on stage.

Top Reasons to Attend

This event prepares pharma for California's 2014 Serialization Mandate.

This event teaches pharma the business case for serialization and traceability in the most pain free and cost effective way

This event provides multiple perspectives throughout the supply chain- pharmacies, manufacturers and wholesalers.



Further information
Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!